Table 1.

Different aspects of the delay in cancer management during the COVID-19 pandemic.

Aspect of the delay	Evidence of the delay	Region	Reference
Delay in screening	46.4 % decrease in weekly cases of cancer diagnosed	United States	Kaufman et al., 2020
	84 % decrease in “2 weeks urgent referral pathways”	United Kingdom	Sud et al., 2020a,b
	94 % decrease in screening rates for breast, colon and cervical cancer	United States	Rebecca Robbins, 2020
	58 % decrease in weekly number of cancers detected	United Kingdom	Rutter et al., 2020
Delay in medical treatment	45–66% reduction in admission to chemotherapy	England and Northern Ireland	Lai et al., 2020
	60 % reduction in chemotherapy appointments	United Kingdom	Wise, 2020
Delay in surgical treatment	56.2–72% reduction in prostate cancer surgery	United States	de Marinis el al., 2020
	10 % modification in surgical approach	Multiples countries	CovidSurg Collaborative, 2020